These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31045243)

  • 1. Potentiating α
    Nomura T; Hawkins NA; Kearney JA; George AL; Contractor A
    J Physiol; 2019 Aug; 597(16):4293-4307. PubMed ID: 31045243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA
    Nakakubo S; Hiramatsu Y; Goto T; Kimura S; Narugami M; Nakajima M; Ueda Y; Shiraishi H; Manabe A; Sharmin D; Cook JM; Egawa K
    Front Pharmacol; 2023; 14():1273633. PubMed ID: 37849734
    [No Abstract]   [Full Text] [Related]  

  • 3. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model.
    Hawkins NA; Lewis M; Hammond RS; Doherty JJ; Kearney JA
    Sci Rep; 2017 Nov; 7(1):15327. PubMed ID: 29127345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabra2 is a genetic modifier of Dravet syndrome in mice.
    Hawkins NA; Nomura T; Duarte S; Barse L; Williams RW; Homanics GE; Mulligan MK; Contractor A; Kearney JA
    Mamm Genome; 2021 Oct; 32(5):350-363. PubMed ID: 34086081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome.
    Anderson LL; Bahceci DA; Hawkins NA; Everett-Morgan D; Banister SD; Kearney JA; Arnold JC
    PLoS One; 2023; 18(1):e0280842. PubMed ID: 36701411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome.
    Anderson LL; Doohan PT; Hawkins NA; Bahceci D; Garai S; Thakur GA; Kearney JA; Arnold JC
    Neuropharmacology; 2022 Mar; 205():108897. PubMed ID: 34822817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
    Miller AR; Hawkins NA; McCollom CE; Kearney JA
    Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the nonselective benzodiazepine lorazepam and the α2 /α3 subunit-selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels.
    Te Beek ET; Chen X; Jacobs GE; Nahon KJ; de Kam ML; Lappalainen J; Cross AJ; van Gerven JM; Hay JL
    Clin Pharmacol Drug Dev; 2015 Mar; 4(2):149-54. PubMed ID: 27128218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
    Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
    J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling in a mouse model of Dravet syndrome.
    Hawkins NA; Calhoun JD; Huffman AM; Kearney JA
    Exp Neurol; 2019 Jan; 311():247-256. PubMed ID: 30347190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome.
    Dyment DA; Schock SC; Deloughery K; Tran MH; Ure K; Nutter LMJ; Creighton A; Yuan J; Banderali U; Comas T; Baumann E; Jezierski A; ; Boycott KM; Mackenzie AE; Martina M
    Genetics; 2020 Aug; 215(4):1055-1066. PubMed ID: 32554600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA
    Jucaite A; Cselényi Z; Lappalainen J; McCarthy DJ; Lee CM; Nyberg S; Varnäs K; Stenkrona P; Halldin C; Cross A; Farde L
    Psychopharmacology (Berl); 2017 Feb; 234(4):707-716. PubMed ID: 28013354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interneuron Desynchronization Precedes Seizures in a Mouse Model of Dravet Syndrome.
    Tran CH; Vaiana M; Nakuci J; Somarowthu A; Goff KM; Goldstein N; Murthy P; Muldoon SF; Goldberg EM
    J Neurosci; 2020 Mar; 40(13):2764-2775. PubMed ID: 32102923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental seizures and mortality result from reducing GABA
    Hines RM; Maric HM; Hines DJ; Modgil A; Panzanelli P; Nakamura Y; Nathanson AJ; Cross A; Deeb T; Brandon NJ; Davies P; Fritschy JM; Schindelin H; Moss SJ
    Nat Commun; 2018 Aug; 9(1):3130. PubMed ID: 30087324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
    Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW
    Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high seizure burden increases several prostaglandin species in the hippocampus of a Scn1a
    Zhou C; Satpute V; Yip KL; Anderson LL; Hawkins N; Kearney J; Arnold JC
    Prostaglandins Other Lipid Mediat; 2024 Jun; 172():106836. PubMed ID: 38599513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome.
    Oakley JC; Cho AR; Cheah CS; Scheuer T; Catterall WA
    J Pharmacol Exp Ther; 2013 May; 345(2):215-24. PubMed ID: 23424217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome.
    Gu F; Parada I; Yang T; Longo FM; Prince DA
    Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35165147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.
    Rubinstein M; Westenbroek RE; Yu FH; Jones CJ; Scheuer T; Catterall WA
    Neurobiol Dis; 2015 Jan; 73():106-17. PubMed ID: 25281316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.